Apixaban Single‐Dose Pharmacokinetics, Bioavailability, Renal Clearance, and Pharmacodynamics Following Intravenous and Oral Administration
Year: 2021
Type: article
Study design: Clinical Trial
DOI: 10.1002/cpdd.990
Institution: Bristol-Myers Squibb (United States)
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3191106360
